Novel Tissues Private Limited, a active private limited company, was established on 30 July 2003 in Bangalore, Karnataka, India. Engaging in paper & packaging products within the manufacturing sector, it holds CIN: U05190KA2003PTC032338. Registered under ROC Roc Bangalore. it is unlisted. It has an authorized capital of ₹2.40 M and a paid-up capital of ₹2.40 M.
It upholds a compliant status. Employing 3 professional, Its leadership includes Adaviappa Balappa Doddamani (Director), Lava Basaningappa Doddamani (Director). Past directors included Mohanan Vechiyot, Sabu Varghese Thelappillil, Thankachan Chempotty. It holds ₹32.05 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2023, with the balance sheet filed on 31 March 2023. It is based at No.2, First Floor City Point13/7, Infantry Road, Bangalore, Karnataka, 570018.
U05190KA2003PTC032338
032338
30 July 2003
₹2.40 M
₹2.40 M
Roc Bangalore
Unlisted
Active
Explore comprehensive insights into Novel Tissues Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Adaviappa Balappa Doddamani | Director | 08 Sep 2011 | Current |
| Lava Basaningappa Doddamani | Director | 11 Nov 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Managing Director | 25 Jul 2010 | Past |
| Pramod Abcsdd | Director | 12 Dec 2008 | Past |
| Pramod Abcsdd | Director | 12 Dec 2008 | Past |
| Pramod Abcsdd | Director | 25 Sep 2013 | Past |
| Pramod Abcsdd | Director | 12 Dec 2008 | Past |
| Pramod Abcsdd | Director | 11 Jan 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Novel Tissues Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 31.91% increase. The company also saw a substantial improvement in profitability, with a 28.21% increase in profit. The company's net worth Soared by an impressive increase of 31.22%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Novel Tissues had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹320,510,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 19 Mar 2025 | Sidbi | ₹2.00 Cr | Open |
| 28 Jun 2024 | Sidbi | ₹5.95 Cr | Open |
| 28 Jun 2024 | Sidbi | ₹2.00 Cr | Open |
| 21 Mar 2023 | Canara Bank | ₹6.00 M | Open |
| 16 Jun 2022 | Sidbi | ₹6.95 Cr | Open |
Explore comprehensive loan charge details -
Novel Tissues has a workforce of 3 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Novel Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Novel Tissues's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 101077732 was registered on 19 Mar 2025. was documented.
The activity A charge with Sidbi amounted to Rs. 59.50 M with Charge ID 100951228 was registered on 28 Jun 2024. was completed.
The activity A charge with Sidbi amounted to Rs. 20.00 M with Charge ID 100951097 was registered on 28 Jun 2024. was completed.
The activity Novel Tissues Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records. was completed.
The activity Novel Tissues Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Bangalore. was completed.
Progress on A charge with Canara Bank amounted to Rs. 6.00 M with Charge ID 100749385 was registered on 21 Mar 2023. was documented.
The CIN of Novel Tissues Private Limited is U05190KA2003PTC032338.
Novel Tissues Private Limited is headquartered at No.2, First Floor City Point13/7, Infantry Road, Bangalore, Karnataka, 570018.
Novel Tissues Private Limited was incorporated on 30 July 2003.
The current directors of Novel Tissues Private Limited are
The primary industry of Novel Tissues Private Limited is Manufacturing.
Novel Tissues Private Limited is unlisted.
The authorized capital of Novel Tissues Private Limited is ₹2.40 M, and the paid-up capital is ₹2.40 M.
The compliance status of Novel Tissues Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX